Free Trial
OTCMKTS:ATRX

Adhera Therapeutics (ATRX) Stock Price, News & Analysis

Adhera Therapeutics logo
$0.0024 0.00 (0.00%)
(As of 11/20/2024 ET)

About Adhera Therapeutics Stock (OTCMKTS:ATRX)

Key Stats

Today's Range
$0.0024
$0.0024
50-Day Range
N/A
52-Week Range
$0.00
$0.05
Volume
N/A
Average Volume
1,571 shs
Market Capitalization
$27,912.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Receive ATRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adhera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATRX Stock News Headlines

Adhera Therapeutics Inc (ATRX)
ATRX Adhera Therapeutics, Inc.
This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
Adhera Therapeutics, Inc. (ATRX)
CGTX Cognition Therapeutics, Inc.
See More Headlines

ATRX Stock Analysis - Frequently Asked Questions

Adhera Therapeutics' stock was trading at $0.03 at the start of the year. Since then, ATRX shares have decreased by 92.0% and is now trading at $0.0024.
View the best growth stocks for 2024 here
.

Shares of Adhera Therapeutics reverse split on the morning of Thursday, October 6th 2022. The 1-20 reverse split was announced on Thursday, October 6th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ATRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adhera Therapeutics investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), PlayAGS (AGS), Assertio (ASRT), Astronics (ATRO), CONSOL Coal Resources (CCR) and Acorda Therapeutics (ACOR).

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ATRX
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($7.02) per share

Miscellaneous

Free Float
8,348,000
Market Cap
$27,912.00
Optionable
Not Optionable
Beta
-0.02
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (OTCMKTS:ATRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners